Back to top
more

Fidelity Select Portfolios Pharmaceuticals Portfolio: (MF: FPHAX)

(NASDAQ Mutual Funds) As of Nov 19, 2019 08:00 PM ET

 Add to portfolio

$22.48 USD

+0.09 (0.40%)

Zacks MF Rank 1-Strong Buy 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Oct 31, 2019

Total Return %* Percentile Rank Objective
YTD 18.30 9
3 months 6.62 2
6 months 10.77 1
1 Year 13.80 1
3 Year 11.24 67
5 Year 4.98 63
10 Year 14.03 56

* Annual for three years and beyond.

Zacks Premium Research for FPHAX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 16.86
% Yield 1.25
% SEC Yield
Net Assets (Mil $) 10/31/2019 720.69
%Turnover 10/31/2019 55.00

Risk

3 Year 5 Year 10 Year
Beta 0.75 0.81 0.78
Alpha 0.10 -3.19 3.35
R Squared 0.50 0.47 0.53
Std. Dev. 12.75 14.09 13.38
Sharpe 0.81 0.35 3.00

Sector / Country Weightings

As of 10/31/2019 % of Portfolio
Health 67.61
Industrial Cyclical 22.70
Other 7.96
Finance 1.40
Services 0.33

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2019)
% of Portfolio Value (Mil$)
ASTRAZENECA PLC 12.50 83.71
JOHNSON & JOHNSON 8.32 55.73
ROCHE HOLDING AG GENUSSS 8.27 55.37
SANOFI ADR 7.56 50.64
BRISTOL MYERS SQUIBB CO 7.24 48.47
MERCK & CO INC 5.90 39.54
NA 5.35 35.80
NOVARTIS AG ADR 4.90 32.85
ELI LILLY & CO 4.47 29.92

Stock Holding % of Net Assets

As Of 5/31/2019
Total Issues 62
Avg. P/E 22.86
Avg. P/Book 5.63
Avg. EPS Growth 11.19
Avg. Market Value (Mil $) 96,376

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 12.12
Small Value 0.00
Foreign Stock 14.03
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 11.34
Foreign Bond 21.76
High Yield Bond 0.00